{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,30]],"date-time":"2025-03-30T04:02:14Z","timestamp":1743307334777,"version":"3.40.3"},"reference-count":17,"publisher":"Keio Journal of Medicine","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Keio J. Med.","Keio j. med"],"published-print":{"date-parts":[[2025]]},"DOI":"10.2302\/kjm.2023-0015-ir","type":"journal-article","created":{"date-parts":[[2023,12,7]],"date-time":"2023-12-07T22:13:43Z","timestamp":1701987223000},"page":"61-66","source":"Crossref","is-referenced-by-count":1,"title":["Pachyonychia Congenita Project: Advancing Research and Drug          Development through Collaboration"],"prefix":"10.2302","volume":"74","author":[{"given":"Janice N.","family":"Schwartz","sequence":"first","affiliation":[{"name":"Pachyonychia Congenita Project, Salt Lake City, Utah, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Holly A.","family":"Evans","sequence":"additional","affiliation":[{"name":"Pachyonychia Congenita Project, Salt Lake City, Utah, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edel A.","family":"O\u2019Toole","sequence":"additional","affiliation":[{"name":"Centre for Cell Biology and Cutaneous Research, Blizard Institute, The              Faculty of Medicine and Dentistry, Queen Mary University of London, London, United              Kingdom"},{"name":"Department of Dermatology, Royal London Hospital, Barts Health NHS Trust,              London, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. David","family":"Hansen","sequence":"additional","affiliation":[{"name":"Pachyonychia Congenita Project, Salt Lake City, Utah, USA"},{"name":"Department of Dermatology, University of Utah, Salt Lake City, Utah,              USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1082","reference":[{"key":"1","unstructured":"1. Smith FJ, Hansen CD, Hull PR, Kaspar RL, McLean          WH, O\u2019Toole E, Sprecher E: Pachyonychia congenita. In: Adam MP, Mirzaa GM, Pagon RA,          Wallace SE, Bean LJH, Gripp KW, Amemiya A, editors. GeneReviews\u00ae 2017 Seattle (WA):          University of Washington. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1280\/"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. McLean WH, Hansen CD, Eliason MJ, Smith FJ: The          phenotypic and molecular genetic features of pachyonychia congenita. J Invest Dermatol          2011; 131: 1015\u20131017. PMID:21430705 https:\/\/doi.org\/10.1038\/jid.2011.59","DOI":"10.1038\/jid.2011.59"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. van Steensel MA, van Geel M, Steijlen PM, Jonkman          MF, Irwin McLean WH, Smith FJ: Clouston syndrome can mimic pachyonychia congenita. J          Invest Dermatol 2003; 121: 1035\u20131038. PMID:14708603          https:\/\/doi.org\/10.1046\/j.1523-1747.2003.12527.x","DOI":"10.1046\/j.1523-1747.2003.12527.x"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4.Eliason MJ, Leachman SA, Feng BJ, Schwartz ME,          Hansen CD. A review of the clinical phenotype of 254 patients with genetically confirmed          pachyonychia congenita. J Am Acad Dermatol 2012; 67 : 680\u2013686. PMID:          https:\/\/doi.org\/10.1016\/j.jaad.2011.12.009","DOI":"10.1016\/j.jaad.2011.12.009"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Samuelov L, Smith FJ, Hansen CD, Sprecher E:          Revisiting pachyonychia congenita: a case\u2010cohort study of 815 patients. Br J Dermatol          2020; 182: 738\u2013746. PMID:31823354 https:\/\/doi.org\/10.1111\/bjd.18794","DOI":"10.1111\/bjd.18794"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Goldberg I, Fruchter D, Meilick A, Schwartz ME,          Sprecher E: Best treatment practices for pachyonychia congenita. J Eur Acad Dermatol          Venereol 2014; 28: 279\u2013285. PMID:23363249          https:\/\/doi.org\/10.1111\/jdv.12098","DOI":"10.1111\/jdv.12098"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Tan XL, Thomas BR, Steele L, Schwartz J, Hansen          CD, O\u2019Toole EA: Genotype-phenotype correlations of neurovascular structures on the feet in          patients with pachyonychia congenita: a cross-sectional study. J Am Acad Dermatol 2022;          87: 1172\u20131174. PMID:35245567 https:\/\/doi.org\/10.1016\/j.jaad.2022.02.050","DOI":"10.1016\/j.jaad.2022.02.050"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Steele L, Schwartz J, Hansen CD, O\u2019Toole EA:          Prevalence and characterization of itch in pachyonychia congenita. JAMA Dermatol 2021;          157: 1378\u20131380. PMID:34468688          https:\/\/doi.org\/10.1001\/jamadermatol.2021.3335","DOI":"10.1001\/jamadermatol.2021.3335"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Shah S, Boen M, Kenner-Bell B, Schwartz M,          Rademaker A, Paller AS: Pachyonychia congenita in pediatric patients: natural history,          features, and impact. JAMA Dermatol 2014; 150: 146\u2013153. PMID:24132595          https:\/\/doi.org\/10.1001\/jamadermatol.2013.6448","DOI":"10.1001\/jamadermatol.2013.6448"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Goldberg I, Mashiah J, Kutz A, Derowe A,          Warshauer E, Schwartz ME, Smith F, Sprecher E, Hansen CD: Symptomatic mucosal involvement          in pachyonychia congenita: challenges in infants and young children. Br J Dermatol 2020;          182: 708\u2013713. PMID:31777952 https:\/\/doi.org\/10.1111\/bjd.18742","DOI":"10.1111\/bjd.18742"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Pavlovsky M, Peled A, Sarig O, Astman N, Malki L,          Meijers O, Assaf S, Schwartz J, Malovitski K, Hansen D, Sprecher E, Samuelov L:          Coexistence of pachyonychia congenita and hidradenitis suppurativa: more than a          coincidence. Br J Dermatol 2022; 187: 392\u2013400. PMID:35606927          https:\/\/doi.org\/10.1111\/bjd.21674","DOI":"10.1111\/bjd.21674"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Wu TT, Eldirany SA, Bunick CG, Teng JM:          Genotype\u2012structurotype\u2012phenotype correlations in patients with pachyonychia congenita. J          Invest Dermatol 2021; 141: 2876\u20132884.          https:\/\/doi.org\/10.1016\/j.jid.2021.03.035","DOI":"10.1016\/j.jid.2021.03.035"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Pan B, Byrnes K, Schwartz M, Hansen CD, Campbell          CM, Krupiczojc M, Caterina MJ, Polydefkis M: Peripheral neuropathic changes in          pachyonychia congenita. Pain 2016; 157: 2843\u20132853. PMID:27776012          https:\/\/doi.org\/10.1097\/j.pain.0000000000000711","DOI":"10.1097\/j.pain.0000000000000711"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Brill S, Sprecher E, Smith FJ, Geva N, Gruener H,          Nahman-Averbuch H, Defrin R: Chronic pain in pachyonychia congenita: evidence for          neuropathic origin. Br J Dermatol 2018; 179: 154\u2013162. PMID:29210461          https:\/\/doi.org\/10.1111\/bjd.16217","DOI":"10.1111\/bjd.16217"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Leachman SA, Hickerson RP, Hull PR, Smith FJ,          Milstone LM, Lane EB, Bale SJ, Roop DR, McLean WH, Kaspar RL: Therapeutic siRNAs for          dominant genetic skin disorders including pachyonychia congenita. J Dermatol Sci 2008; 51:          151\u2013157. PMID:18495438 https:\/\/doi.org\/10.1016\/j.jdermsci.2008.04.003","DOI":"10.1016\/j.jdermsci.2008.04.003"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Fu T, Leachman SA, Wilson NJ, Smith FJ, Schwartz          ME, Tang JY: Genotype\u2013phenotype correlations among pachyonychia congenita patients with          K16 mutations. J Invest Dermatol 2011; 131: 1025\u20131028. PMID:21160496          https:\/\/doi.org\/10.1038\/jid.2010.373","DOI":"10.1038\/jid.2010.373"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Spaunhurst KM, Hogendorf AM, Smith FJ, Lingala B,          Schwartz ME, Cywinska-Bernas A, Zeman KJ, Tang JY: Pachyonychia congenita patients with          mutations in KRT6A have more extensive disease compared with patients who have mutations          in KRT16. Br J Dermatol 2012; 166: 875\u2013878. PMID:22098151          https:\/\/doi.org\/10.1111\/j.1365-2133.2011.10745.x","DOI":"10.1111\/j.1365-2133.2011.10745.x"}],"container-title":["The Keio Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/kjm\/74\/1\/74_2023-0015-IR\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T04:04:16Z","timestamp":1743221056000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/kjm\/74\/1\/74_2023-0015-IR\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.2302\/kjm.2023-0015-ir","relation":{},"ISSN":["0022-9717","1880-1293"],"issn-type":[{"type":"print","value":"0022-9717"},{"type":"electronic","value":"1880-1293"}],"subject":[],"published":{"date-parts":[[2025]]},"article-number":"2023-0015-IR"}}